Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Tubular biomarkers and histology in lupus nephritis.

  • Source: International Journal of Rheumatic Diseases. Jun2024, Vol. 27 Issue 6, p1-8. 8p.

Record details

×
Academic Journal

Phosphorylated vimentin at Ser72 is associated with epithelial–mesenchymal transition in lupus nephritis.

  • Source: International Journal of Rheumatic Diseases. Jan2024, Vol. 27 Issue 1, p1-10. 10p.

Record details

×
Academic Journal

Population‐wide long‐term study of incidence, renal failure, and mortality rates for lupus nephritis.

  • Source: International Journal of Rheumatic Diseases. Feb2024, Vol. 27 Issue 2, p1-8. 8p.

Record details

×
Academic Journal

Identification of potent target and its mechanism of action of Tripterygium wilfordii Hook F in the treatment of lupus nephritis.

  • Source: International Journal of Rheumatic Diseases. Aug2023, Vol. 26 Issue 8, p1529-1539. 11p.

Record details

×
Academic Journal

Overlapping drug‐induced vasculitis, ANCA‐associated vasculitis, and lupus nephritis caused by low‐dose hydralazine.

  • Source: International Journal of Rheumatic Diseases. Nov2023, Vol. 26 Issue 11, p2272-2277. 6p.

Record details

×
Academic Journal

MPO-ANCA-positive granulomatosis with polyangiitis and concurrent IgG4-related disease with periaortitis and tubulointerstitial nephritis: A case report of a new overlap syndrome?

  • Authors : Kuske L; Department of Rheumatology, Medical School Hannover, Hannover, Germany.; Khalifa A

Subjects: Immunoglobulin G4-Related Disease*/Immunoglobulin G4-Related Disease*/Immunoglobulin G4-Related Disease*/complications ; Immunoglobulin G4-Related Disease*/Immunoglobulin G4-Related Disease*/Immunoglobulin G4-Related Disease*/diagnosis ; Immunoglobulin G4-Related Disease*/Immunoglobulin G4-Related Disease*/Immunoglobulin G4-Related Disease*/drug therapy

  • Source: International journal of rheumatic diseases [Int J Rheum Dis] 2023 Sep; Vol. 26 (9), pp. 1821-1825. Date of Electronic Publication: 2023 Mar 27.Publisher: Wiley on behalf of the Asia Pacific League of Associations for Rheumatology Country of Publication: England NLM ID: 101474930 Publication Model:

Record details

×
Academic Journal

Efficacy and safety of an anti‐CD20 monoclonal antibody, rituximab, for lupus nephritis: A meta‐analysis.

  • Source: International Journal of Rheumatic Diseases. Feb2022, Vol. 25 Issue 2, p101-109. 9p.

Record details

×
Academic Journal

Comparison of renal remission and relapse‐free rate in initial‐ and delayed‐onset lupus nephritis.

  • Source: International Journal of Rheumatic Diseases. Dec2021, Vol. 24 Issue 12, p1500-1509. 10p.

Record details

×
Academic Journal

A patient with refractory proliferative lupus nephritis treated with telitacicept: A case report.

  • Authors : Chen JW; The First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China.; Department of Rheumatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.

Subjects: Lupus Nephritis*/Lupus Nephritis*/Lupus Nephritis*/diagnosis ; Lupus Nephritis*/Lupus Nephritis*/Lupus Nephritis*/drug therapy ; Lupus Nephritis*/Lupus Nephritis*/Lupus Nephritis*/pathology

  • Source: International journal of rheumatic diseases [Int J Rheum Dis] 2023 Jul; Vol. 26 (7), pp. 1417-1421. Date of Electronic Publication: 2023 May 23.Publisher: Wiley on behalf of the Asia Pacific League of Associations for Rheumatology Country of Publication: England NLM ID: 101474930 Publication Model:

Record details

×
Academic Journal

Higher serum levels of autotaxin and phosphatidylserine‐specific phospholipase A1 in patients with lupus nephritis.

  • Source: International Journal of Rheumatic Diseases. Feb2021, Vol. 24 Issue 2, p231-239. 9p.

Record details

×
  • 1-10 of  672 results for ""Nephritis""